Schedule 13D ownership disclosure
Ventyx Biosciences Inc
Common stock, par value $0.0001 per share · CUSIP: 92332V107
Event date: 2026-01-07
- Filing-level shares
- 4,122,975
- Percent of class
- 5.8%
- Subramaniam SomuReported CIK 0001508910
Shares: 4,122,975 · Class: 5.8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000929638-26-000112
- Form type
- SCHEDULE 13D/A
- Filer
- Subramaniam Somu
- CIK
- CIK 1508910
- Filed
- Jan 09, 2026
- Reporting period
- Jan 07, 2026
- Description
- Schedule 13D beneficial ownership